Integrated services for medicinal cannabis brands, from cultivation and sourcing to supply chain coordination, fulfilment and professional networks.
Building a medicinal cannabis brand requires more than sourcing a product. It requires connected relationships, coordinated operations and a clear route to market.
Botannic sits at the centre of that process. We bring together Australian cultivation partnerships, sourcing and procurement, sponsorship, import and export services, compliant storage, order fulfilment, and pharmacy and prescriber networks.
Our role is to connect those capabilities around your brand's needs.
Medicinal cannabis brands operate across a complex network of suppliers, service providers and healthcare professionals. When those relationships are managed separately, responsibilities can become unclear and coordination can take valuable time away from building the business.
Botannic helps brands connect the right partners, manage handovers and maintain visibility across their supply chain.
Fewer disconnected relationships. Clearer responsibilities. A more coordinated operation.
One partner to coordinate the agreed services across your supply chain.
Integrated partnerships with a cohort of local cultivators.
Services spanning sourcing, sponsorship, international supply, storage, fulfilment and professional networks.
Support for an individual requirement or a broader operating model.
A shared understanding of responsibilities, dependencies and next steps across participating partners.
Martin Bryden has worked in the Australian medicinal cannabis sector since 2018, with commercial leadership experience spanning production, telehealth clinics, procurement, storage and distribution, sales and marketing. His experience across the supply chain brings a practical understanding of how to connect cultivation, product supply and patient access.
Martin focuses on building strong partnerships, developing integrated operations and helping businesses establish and grow their presence in the medicinal cannabis market.
Ed is a life sciences leader and strategic executive working at the intersection of complex pharmacology, commercial strategy and B2B growth. He brings over six years in senior executive roles within the Australian cannabis market, complemented by foundational leadership in multinational pharmaceutical corporations.
A former Biochemistry lecturer, Ed earned a Ministry of Defence PhD scholarship at King's College London, where his research identified key mechanisms surrounding cannabinoid (CB) receptor mediation in High Pressure Neurological Syndrome (HPNS) and migraines.
By combining deep scientific acumen with executive B2B expertise, Ed excels at translating sophisticated research into scalable market strategies, building high-value industry relationships and steering organisations through complex regulatory and commercial landscapes.
Shaun has held senior commercial and clinical roles across the Asia Pacific in large multinational companies, working across cultures, diverse regulatory environments and a broad range of projects.
He has managed small and large teams focused on in-house and 3PL distribution, sales, marketing, medical affairs, product training, supply chain, regulatory outcomes and clinical trials. He has worked in the medicinal cannabis industry in Australia since 2020.
Shaun is part owner and operator of the Canntic Group, which is engaged in all aspects of the medicinal cannabis industry in Australia, New Zealand and internationally.
Whether you are developing a new brand, reviewing your supply arrangements or expanding your operations, Botannic brings the relevant capabilities together.
Start a conversation